Brief: Harrow Announces Fourth Quarter And Year-End 2023 Financial Results
19/03/2024 22:26
March 19 (Reuters) - Harrow Inc HROW.O :
* HARROW ANNOUNCES FOURTH QUARTER AND YEAR-END 2023
FINANCIAL
RESULTS
* HARROW INC - QTRLY LOSS PER SHARE $0.26
* HARROW INC - QTRLY ADJUSTED LOSS PER SHARE $0.20
Source text for Eikon: ID:nBw63kCRHa
Further company coverage: HROW.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates